IVF & Fertility / New York City
Weill Cornell (CRMI)
How to read this firm's data
How to read this firm's data
Header tiles
- Rank
- Position among businesses named in the latest scan.
- Mention rate
- The share of eligible AI responses in the current ranking that named the business.
Charts
- Rank trend
- Each dot is one published ranking, newest on the right. A flat line means this firm's rank didn't move.
- Per-AI breakdown
- Responses from each assistant that named this firm.
- By question type
- Mentions grouped by what the buyer was asking.
Practice context for IVF & Fertility · Not yet reviewed
A sourced business description has not been added yet. Assistant mentions alone do not verify the firm's services.
Practice eligibility has not been reviewed for this market. This is unknown, not an exclusion.
Practice evidence and AI measurements are assessed separately. Mentions do not establish suitability.
Market detail: IVF & Fertility · New York City
Position
#329
of 676 firms · Oct 11, 2026
Mention rate
0.1%
1 of 1,128 eligible responses
Rank vs mention rate
2 snapshots · 14 days
Rank ranged #221 to #329 · mention rate 0.1%–0.2%
How to read this chart
How to read: each dot is one snapshot. The green line is where this firm ranked among peers on that day. The dashed amber line is the mention rate — the share of AI responses in that snapshot that named this firm at all.
Rank and mention rate use different scales, so the two lines are placed side-by-side, not on top of each other. A firm can hold rank while mention rate drifts (fewer responses named anyone) or improve rank without moving mention rate (peers dropped out).
Research details Historical appearances, assistant counts and question types · all roles, separate from qualified recommendations.
All-time results for this market
Business appeared Jul 13, 2026–Oct 11, 2026
- Responses analyzed
- 8,942
- Responses naming business
- 9
- Historical appearance rate
- 0.1%
- Dates with published rank
- 9
These raw appearance totals cover all retained responses for this city and category, across all question types and roles, including sources and incidental mentions. They are not qualified recommendation counts. Appearance dates show when responses named this business; published rank dates can include repeated use of those responses. Current rank and confidence use the latest dated ranking.
Per-AI breakdown
Counts cover all published Atlas research for this market.
- Claude
- 2 mentions
- ChatGPT
- 0 mentions
- Gemini
- 1 mention
- Perplexity
- 6 mentions
By question type
All-time mentions grouped by the type of question the buyer asked.
- Situation
- 4 mentions
- Decision
- 3 mentions
- Learning
- 1 mention
- Constraints
- 1 mention
Peer firms in New York City ivf & fertility
Current ranks and mention rates · Oct 11, 2026 edition.
#1
RMA of New York: Westside
49.4% current mention rate · 4/4 AI
#2
NYU Langone Fertility Center
42.6% current mention rate · 4/4 AI
#3
Columbia University Fertility Center
36.1% current mention rate · 4/4 AI
#4
Weill Cornell Medicine Center for Reproductive Medicine and Infertility
28.0% current mention rate · 4/4 AI
#5
CCRM Fertility of New York
24.1% current mention rate · 4/4 AI
#6
New Hope Fertility Center
23.6% current mention rate · 4/4 AI
#7
Reproductive Medicine Associates of New York (RMA NY)
15.7% current mention rate · 3/4 AI
#8
Extend Fertility
12.9% current mention rate · 4/4 AI
Unclaimed listing — claim this profile
Atlas created this profile after AI assistants named the business. Claim it to confirm the business details; we'll reply from support@viclaro.app.
Buyer questions and AI answers
Simulated buyer questions from Atlas’s test dataset, paired with AI answers that mentioned this firm or professional. Open to see the questions and what was said.
9 AI answers with recorded context · 0 reviewed in context
Atlas asks AI assistants questions written from the perspective of people seeking services in a particular city and situation. Each example connects a simulated buyer question to an answer that named this firm or professional. A name can appear as a recommendation, a related adviser, a comparison, or even an option the assistant advises against.
A mention does not verify services, eligibility or suitability. Context review explains how the name was used; it does not verify the assistant’s claims. Explore the test questions and methodology.
Simulated buyer question · IVF & Fertility · New York City · Medical Four losses. All first trimester, all after a heartbeat. I'm 36. My OB finally referred me out. We're in New York City. I don't want another RE who runs the sam... perplexity/sonar 2026-10-11 18:37:01 How the name appeared: Uncertain Open question and AI answer
What the simulated buyer asked
Four losses. All first trimester, all after a heartbeat. I'm 36. My OB finally referred me out. We're in New York City. I don't want another RE who runs the same MTHFR/anticardiolipin panel and shrugs. Who actually does a real RPL workup — immune, ERA, karyotype on tissue if we can get it — and knows what to do with the answers?
No name-matched excerpt is available; the extracted appearance needs review.
How to read this mention
The role of this name in the answer is uncertain or has not been reviewed.
Unreviewed contextual evidence; no qualification established.
Market: IVF & Fertility · New York City · Medical
Factual accuracy: unverified · Practice fit: unknown
Context review: unreviewed. This is separate from practice eligibility and ranking.
No source URLs were recorded for this answer.
Simulated buyer question · IVF & Fertility · New York City · Medical Four losses. All first trimester, all after a heartbeat. I'm 36. My OB finally referred me out. We're in New York City. I don't want another RE who runs the sam... perplexity/sonar 2026-09-27 07:48:25 How the name appeared: Uncertain Open question and AI answer
What the simulated buyer asked
Four losses. All first trimester, all after a heartbeat. I'm 36. My OB finally referred me out. We're in New York City. I don't want another RE who runs the same MTHFR/anticardiolipin panel and shrugs. Who actually does a real RPL workup — immune, ERA, karyotype on tissue if we can get it — and knows what to do with the answers?
No name-matched excerpt is available; the extracted appearance needs review.
How to read this mention
The role of this name in the answer is uncertain or has not been reviewed.
Unreviewed contextual evidence; no qualification established.
Market: IVF & Fertility · New York City · Medical
Factual accuracy: unverified · Practice fit: unknown
Context review: unreviewed. This is separate from practice eligibility and ranking.
No source URLs were recorded for this answer.
Simulated buyer question · IVF & Fertility · New York City · Medical For IVF in New York City with a complicated case (RPL, endo, one failed cycle) — should I go to a big academic program (Weill Cornell, Columbia, NYU) or one of... perplexity/sonar 2026-09-27 07:19:59 How the name appeared: Uncertain Open question and AI answer
What the simulated buyer asked
For IVF in New York City with a complicated case (RPL, endo, one failed cycle) — should I go to a big academic program (Weill Cornell, Columbia, NYU) or one of the private groups (RMA, CCRM-affiliated, Kofinas, etc.)? Real pros and cons of each, and name specific clinics.
No name-matched excerpt is available; the extracted appearance needs review.
How to read this mention
The role of this name in the answer is uncertain or has not been reviewed.
Unreviewed contextual evidence; no qualification established.
Market: IVF & Fertility · New York City · Medical
Factual accuracy: unverified · Practice fit: unknown
Context review: unreviewed. This is separate from practice eligibility and ranking.
No source URLs were recorded for this answer.
Selected examples from the test dataset are shown here. Excerpts show part of an answer; full response records remain part of the audit. Each market has its own question set and sample, so these examples do not establish an overall rank.
Field notes on reading these rankings
Turn this ranking into a decision.
Get the complete competitive gap, the public evidence behind it, and the three changes worth testing first.
Request the competitive brief →